Brooks Laboratories Limited (NSE:BROOKS)

Market Cap	4.43B
Revenue (ttm)	825.57M
Net Income (ttm)	-99.67M
Shares Out	29.78M
EPS (ttm)	-3.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,525
Average Volume	18,447
Open	149.25
Previous Close	148.78
Day's Range	145.11 - 156.21
52-Week Range	94.42 - 198.86
Beta	0.71
RSI	49.22
Earnings Date	Aug 12, 2025

About Akoya Biosciences

Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 293
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BROOKS

Financial Performance

In 2024, Brooks Laboratories's revenue was 825.57 million, an increase of 3.86% compared to the previous year's 794.86 million. Losses were -99.67 million, -49.13% less than in 2023.